290 related articles for article (PubMed ID: 10930537)
21. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
22. Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration.
Lin KI; Baraban JM; Ratan RR
Cell Death Differ; 1998 Jul; 5(7):577-83. PubMed ID: 10200512
[TBL] [Abstract][Full Text] [Related]
23. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
Kim HT; Qiang W; Wong PK; Stoica G
J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex.
Almond JB; Snowden RT; Hunter A; Dinsdale D; Cain K; Cohen GM
Leukemia; 2001 Sep; 15(9):1388-97. PubMed ID: 11516099
[TBL] [Abstract][Full Text] [Related]
25. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
29. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
30. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression.
Jiang B; Xu S; Hou X; Pimentel DR; Brecher P; Cohen RA
J Biol Chem; 2004 Jan; 279(2):1323-9. PubMed ID: 14581482
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.
Pajonk F; Pajonk K; McBride WH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1025-32. PubMed ID: 10863075
[TBL] [Abstract][Full Text] [Related]
32. Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance.
Lin ZP; Boller YC; Amer SM; Russell RL; Pacelli KA; Patierno SR; Kennedy KA
Cancer Res; 1998 Jul; 58(14):3059-65. PubMed ID: 9679971
[TBL] [Abstract][Full Text] [Related]
33. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
34. Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
Kim KW; Kim BJ; Chung CW; Jo DG; Kim IK; Song YH; Kwon YK; Woo HN; Jung YK
J Cell Biochem; 2002; 85(2):334-45. PubMed ID: 11948689
[TBL] [Abstract][Full Text] [Related]
35. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
Li N; Karin M
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13012-7. PubMed ID: 9789032
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of NF-kappaB by IkappaB prevents cytokine-induced NO production and promotes enterocyte apoptosis in vitro.
Potoka DA; Nadler EP; Zhou X; Zhang XR; Upperman JS; Ford HR
Shock; 2000 Sep; 14(3):366-73. PubMed ID: 11028558
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis.
Meiners S; Laule M; Rother W; Guenther C; Prauka I; Muschick P; Baumann G; Kloetzel PM; Stangl K
Circulation; 2002 Jan; 105(4):483-9. PubMed ID: 11815432
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
[TBL] [Abstract][Full Text] [Related]
40. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.
Chen C; Lin H; Karanes C; Pettit GR; Chen BD
Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
